Anti-ulcer agents explained

Anti-ulcer agents are medications or supplements used to cure the damage of mucosal layer on organs to prevent the damage from further extending to deeper regions to cause complications.

An anti-ulcer medication for treating mouth ulcer is triamcinolone, a corticosteroid. Other anti-ulcer supplements include vitamin B2 and vitamin B12.

Antibiotics and agents to reduce gastric acid secretion are used in combinations to treat Helicobacter pylori (H. pylori)-induced peptic ulcer disease (PUD), an ulceration in the gastric region. Antibiotics include amoxicillin, clarithromycin and metronidazole. Bismuth subsalicylate is an antimicrobial agent of another drug class that can also be used to eradicate H. pylori for treating PUD. Agents for suppressing gastric acid secretion are proton-pump inhibitors (PPI), such as lansoprazole, pantoprazole, rabeprazole, omeprazole and esomeprazole.

Anti-ulcer agents to treat mouth ulcer

Triamcinolone, vitamin B2 and vitamin B12 can be used to treat mouth ulcers, which are confined, shallow, round to oval-shaped lesions that sometimes contain yellowish adherent central exudate and give a pain sensation.[1]

Triamcinolone

Triamcinolone is a corticosteroid, which can be applied on the ulcerated region to cure mouth ulcer by its anti-inflammatory action.

Medical uses and available forms

Triamcinolone is mainly used to treat recurrent mild to moderate aphthous stomatitis, also known as mouth ulcer.[2] This medication should show anti-ulcer effect or repair of oral tissues in seven days. This corticosteroid is available in the formulation of oral paste.

Mechanism of action

Triamcinolone exerts its anti-inflammatory effect by decreasing the formation, release and activity of inflammatory substances originated from human bodies. By reducing the inflammation, it can achieve anti-ulcer effect.[3]

Adverse effects

Triamcinolone commonly cause local side effects only. The undesirable effects may be oral mucosa changes that breaks the inner mouth mucosal layer. The damage in the mucosa may also cause redness and irritation on the application area. In rare situations, systemic side effects may occur. Serious adverse drug reactions of this corticosteroid are Cushing's syndrome, symptoms and signs include high blood glucose level, excretion of glucose in urine and weight gain. These undesirable effects can be prevented by not applying triamcinolone in large area.[4]

Contraindications

Triamcinolone should not be used if patients have hypersensitivity to triamcinolone.[5] Moreover, patients with fungal, viral, or bacterial infections in the mouth or throat should not consider using this medication.

Interactions

Triamcinolone may interact with medications which are CYP3A4 inhibitors. CYP3A4 inhibitor may decrease the break down of triamcinolone which increases its amount in patients' body to cause toxicity. Examples of CYP3A4 inhibitors include clarithromycin, verapamil, ketoconazole and anti-viral drugs, including nirmatrelvir and ritonavir. These medications should not be administered with triamcinolone as drug-drug interactions may result.[6] [7]

Vitamin B2

Vitamin B2 is a supplement for promoting cell growth. It can treat mouth ulcer without causing serious side effects.

Medical uses and available forms

Vitamin B2, also known as riboflavin, can cure mouth ulcer.[8] The common formulation of vitamin B2 is in tablet form for oral administration.[9]

Mechanism of action

Vitamin B2 is essential for mucosal growth. Sufficient intake of vitamin B2 can repair the damaged oral tissues efficiently. This can heal the mouth ulcer.

Adverse effects

Adverse effects of vitamin B2 are mild. A common side effect of taking vitamin B2 is the production of yellow-orange urine. To address this problem, drinking more water may help to reduce the colour intensity of urine.[10]

Contraindications

Contraindications of vitamin B2 is uncommon. [11]

Interactions

Interactions of vitamin B2 with other drugs is uncommon.[12]

Vitamin B12

Medical uses and available forms

Vitamin B12 is a supplement that can heal mouth ulcer. [13] It exists in tablet formulation and can be taken orally.

Mechanism of action

Vitamin B12 is essential for cell duplication and formation of blood cells. It can promote cell growth to repair the ulcerated regions in the mouth.

Adverse effects

Oral administration of vitamin B12 may increase infection risks.[14] Side effects in other body systems are uncommon for oral formulation.

Contraindications

Patients with hypersensitivity to vitamin B12 should not take the vitamin B12 supplement.

Interactions

Heavy alcohol consumption over 2 weeks may decrease vitamin B12 absorption, which may reduce the effectiveness of this anti-ulcer agent.[15] Vitamin B12 may also interact with other medications. The therapeutic effect of this supplement may be reduced by chloramphenicol.[16]

Anti-ulcer agents to treat peptic ulcer disease (PUD)

Several anti-ulcer dosing regimens that combine antibiotics and proton pump inhibitors (PPI) to treat helicobacter pylori (H. pylori) induced peptic ulcer disease (PUD). The role of antibiotic in the therapies is to eradicate H. pylori, while the action of PPI is to reduce gastric acid secretion. The anti-ulcer dosing regimens generally repair the injury of gastric mucosal layer in PUD.

Examples of dosing regimen: [17]

  1. Amoxicillin + clarithromycin + PPI
  2. Bismuth subsalicylate + tetracycline + metronidazole + PPI
  3. PPI + amoxicillin for 5 days, then PPI + clarithromycin + metronidazole for 5 days

All therapies last for at least 2 weeks.[18] Ulcerations that remain active beyond 2 weeks may require longer treatment period.

Antibiotics

For all antibiotics, patients need to finish the whole course of treatment to prevent antimicrobial resistance. Recurrent ulceration may occur if H. pylori is not eradicated.[19]

Amoxicillin

Amoxicillin is an antibiotic that can be used in combination with other drugs to cure PUD.[20] Amoxicillin has a minimal resistance rate in H. Pylori of 2% worldwide.[21] This agent is used in first line treatment unless contraindicated.

Medical uses and available forms

Amoxicillin is a penicillin antibiotic.[22] One of its indications is to eradicate H. pylori.[23] It is available as oral capsules.[24]

Mechanism of action

Amoxicillin can inhibit cell wall mucopeptide biosynthesis, leading to bacterial death. This can reduce the ulcer recurrence risk.[25]

Adverse effects

Amoxicillin may cause gastrointestinal discomfort, namely nausea and vomiting.[26] To eliminate these adverse effects, take the medication after a meal. Besides, this antibiotic may disrupt bowel microflora and induce diarrhea.[27] In rare cases, amoxicillin may induce risk of Clostridium difficile-associated diarrhea.[28]

Contraindications

Patients with hypersensitivity or drug allergy to amoxicillin or other beta-lactams should not use this drug.[29]

Interactions

Patients using allopurinol may increase risk of allergic reactions.[30] Allergic responses range from skin rash to anaphylaxis.

Clarithromycin

Clarithromycin is an antibiotic used in combined therapies for treating PUD. Given the resistance of clarithromycin is higher than 15% in all WHO regions, it is still being used for eradicating H. pylori.[31]

Medical uses and available forms

Clarithromycin is an antibiotic under the class of macrolide.[32] It is indicated for the eradication of H. pylori to minimize the probability of duodenal ulcer recurrence by being a component of the combination therapy.[33] [34] Clarithromycin is available as tablets which should be taken orally.[35] [36] [37]

Mechanism of action

Clarithromycin binds to the P site of 50S ribosomal subunit reversibly, which inhibits both the RNA-dependent protein synthesis and bacterial growth.[38] This reversible inhibition can kill the H. pylori in the gastric region.

Adverse effects

Clarithromycin may cause gastrointestinal adverse effects including vomiting, nausea, taste alteration and abdominal pain.[39] This medication can also cause liver toxicity. Symptoms of liver damage include anorexia, dark urine, jaundice, tender abdomen and pruritus. To assess the liver function, ALT/AST should be closely monitored. This antibiotic may also induce rare side effects in the cardiovascular system, such as QT prolongation, which may precipitate arrhythmia.[40]

Contraindications

Patients with hypersensitivity to clarithromycin, erythromycin, or any of the macrolide antibiotics should not take this medication.[41] Additionally, if patients are diagnosed with liver dysfunction before the treatment, clarithromycin is also contraindicated.

Interactions

Clarithromycin should not be taken with CYP3A4 inhibitors, for instance, atorvastatin, amlodipine and warfarin.[42] Specifically, statins should be stopped for the period of therapy and resumed once H. Pylori is eradicated.[43]

Metronidazole

Metronidazole is an antibiotic with an off-label use in eradicating H. pylori for treating gastric ulceration. Resistance of metronidazole is above 15% worldwide. It is likely to be resistant so is not the first line choice of treatment.[44] However, resistance is variable, that can be overcome by high dosages and in combination with other antibiotics.[45]

Medical uses and available forms

Metronidazole is an nitroimidazole antibiotic which can treat PUD. Metronidazole as available as tablets for oral administration.

Mechanism of action

Metronidazole inhibits nucleic acid synthesis by disrupting DNA and breaking the strand of the bacteria. This kills the H. pylori.[46]

Adverse effects

The metronidazole tablet may have an unpleasant metallic taste, deteriorating drug compliance.[47] This medication may also induce rare side effect in the central nervous system, including neurotoxicity (encephalopathy, peripheral neuropathy, seizure).[48] [49] [50] [51]

Contraindications

Patients should not drink alcohol to prevent disulfiram-like reactions, with symptoms of flushing, tachycardia, palpitations, nausea, vomiting. Alcohol should only be taken at least 3 days after the last dose of metronidazole.[52] [53]

Interactions

Metronidazole should not be used with carbocisteine due to the enhancement of carbocisteine toxicity.[54] Metronidazole also interacts with mebendazole to increase the risk of severe skin response like toxic epidermal necrolysis and Steven-Johnson syndrome

Other antimicrobial drugs

Bismuth subsalicylate

Bismuth subsalicylate is an antimicrobial drug in the off-labelled dosing regimen for H. pylori-induced PUD.[55] Its indication is to eradicate H. Pylori.[56]

Medical uses and available forms

Bismuth subsalicylate exists in the form of tablets and should be administered orally.[57]

Mechanism of action

Bismuth subsalicylate consists of the bismuth and subsalicylate moiety. The bismuth in bismuth subsalicylate has antibacterial activity against H pylori. The salicylate moiety stimulates prostaglandins and exerts local gastroprotective effects.

Adverse effects

Common side effect is darkening of the tongue and teeth.[58] It also causes darkening of faeces which may confuse with the signs of gastrointestinal bleeding.[59] In renal failure patients, long-term use of bismuth may cause toxicity, resulting in encephalopathy (ataxia, headache, confusion, seizures).

Contraindications

Patients who are allergic to aspirin or taking other salicylates should not use bismuth salicylate.

Interactions

As bismuth binds to food and experiences a reduction of efficacy, patients should take the medication on an empty stomach.[60]

Proton pump inhibitor (PPI)

Proton pump inhibitor (PPI) is a group of medications that reduce secretion of gastric acid to prevent further deterioration of gastric ulceration.[61]

Medical uses and available forms

PPI exist in the forms of oral enteric coated tablets or enteric granules capped within capsules. To ensure the effectiveness of the medication, patients should swallow the whole tablet. They should not chew or cut the tablets, nor open the capsule and grind the granules.[62] To add on, patients should take the medicine 30 to 60 minutes before meals.[63] Different medications in this class has different standard doses:

MedicationDosage
Lansoprazole30mg
Omeprazole20mg
Pantoprazole40mg
Rabeprazole20mg
Esomeprazole20mg

Mechanism of action

PPI irreversibly inhibits H+/K+ ATPase proton pump on gastric parietal cell to create profound, long-lasting antisecretory effect on gastric acid.[64]

Adverse effects

PPI may induce common side effects including headache, diarrhoea, abdominal pain and nausea. Taking PPI may rarely cause community acquired pneumonia. Prolonged use of PPI may be associated with intestinal clostridium difficile infection, low magnesium level, Vitamin B12 and iron deficiency, osteoporosis, acute kidney inflammation, and gastric cancer.[65] [66] [67] [68] [69] [70]

Contraindications

Patients who have hypersensitivity to PPIs, or using products containing rilpivirine concomitantly should not take PPI.[71]

Interactions

Due to drug-drug interactions, patients taking clopidogrel, an antiplatelet drug, should not take PPI except rabeprazole.[72] Since PPI changes the acidity of the gastric content, patients taking ketoconazole, atazanavir, iron, erlotinib, and MMF should not take PPI at the same time.[73]

Notes and References

  1. Web site: April 1, 2024 . Oral lesions. Aphthous ulcerations. . UpToDate..
  2. Taylor J, Glenny AM, Walsh T, Brocklehurst P, Riley P, Gorodkin R, Pemberton MN . Jennifer . Taylor . Interventions for the management of oral ulcers in Behçet's disease . The Cochrane Database of Systematic Reviews . 2014 . 9 . CD011018 . September 2014 . 25254615 . 6872426 . 10.1002/14651858.CD011018.pub2 .
  3. Web site: Triamcinolone (topical): Drug information. Pharmacology: Mechanism of action. . 2024-03-29 . UpToDate. .
  4. Web site: Triamcinolone (topical): Drug information. Adverse reactions. . 2024-03-29 . UpToDate..
  5. Web site: Triamcinolone (topical): Drug information. Contraindications. . UpToDate..
  6. Web site: Triamcinolone (topical): Drug information. Interactions: Drug interactions. . 2024-03-29 . UpToDate..
  7. Web site: Antivirals (Corticosteroids - interactions of corticosteroids). . 2024-03-29 . Martindale. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  8. Park KK, Brodell RT, Helms SE . Angular cheilitis, part 2: nutritional, systemic, and drug-related causes and treatment . Cutis . 88 . 1 . 27–32 . July 2011 . 21877503 .
  9. Web site: Vitamin B2 (riboflavin): Drug information. Dosing. . April 1, 2024 . UpToDate..
  10. Web site: Vitamin B2 substances: Adverse effects and precautions. . 2024-03-29 . Martindale. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  11. Web site: Vitamin B2 (riboflavin): Drug information. Contraindications/warnings. . April 4, 2024 . UpToDate..
  12. Web site: Vitamin B2 (riboflavin): Drug information. Drug interactions. . April 4, 2024 . UpToDate..
  13. Mousavi T, Jalali H, Moosazadeh M . Hematological parameters in patients with recurrent Aphthous Stomatitis: a systematic review and meta-analysis . BMC Oral Health . 24 . 1 . 339 . March 2024 . 38493289 . 10943797 . 10.1186/s12903-024-04072-5 . free .
  14. Web site: Cyanocobalamin (vitamin B12): Drug information. Adverse reactions. . 2024-03-29 . UpToDate..
  15. Web site: Cyanocobalamin (vitamin B12): Drug information. Dosing: Adult. . 2024-03-29 . UpToDate..
  16. Web site: Cyanocobalamin (vitamin B12): Drug information. Drug interactions. . 2024-03-29 . UpToDate..
  17. Book: Wells BG, Schwinghammer TL, DiPiro JT, DiPiro CV . Pharmacotherapy Handbook . 10th Peptic ulcer disease. . McGraw-Hill Education . 2017 . 978-1-259-58643-9.
  18. Gisbert JP, Pajares JM . Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? . Alimentary Pharmacology & Therapeutics . 21 . 7 . 795–804 . April 2005 . 15801914 . 10.1111/j.1365-2036.2005.02418.x . 2024-04-08 . live . https://web.archive.org/web/20240408155357/https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2005.02418.x . 2024-04-08 .
  19. Web site: Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects. Mechanisms of bacterial resistance. . 2024-04-04 . Uptodate..
  20. Web site: Amoxicillin: Drug information. Use: Labeled Indications. . 2024-04-03 . Uptodate..
  21. Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VW, Wu JC, Chan FK, Sung JJ, Kaplan GG, Ng SC . 6 . Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis . Gastroenterology . 153 . 2 . 420–429 . August 2017 . 28456631 . 10.1053/j.gastro.2017.04.022 . 2024-04-08 . live . https://web.archive.org/web/20240410173109/https://linkinghub.elsevier.com/retrieve/pii/S0016508517355312 . 2024-04-10 . free .
  22. Web site: Amoxicillin: Drug information. Pharmacologic Category. . 2024-04-01 . Uptodate..
  23. Web site: Amoxicillin: Drug information. Mechanism of Action . 2024-04-01 . Uptodate..
  24. Web site: Amoxicillin: Drug information. Dosage Forms: US. . 2024-04-03 . Uptodate..
  25. Web site: Amoxicillin: Drug information. Use: Labeled Indications . 2024-04-01 . Uptodate..
  26. Web site: Amoxicillin: Drug information. Adverse Reactions (Significant): Considerations. . 2024-04-01 . Uptodate..
  27. Zhou H, Xu Q, Liu Y, Guo LT . Risk factors, incidence, and morbidity associated with antibiotic-associated diarrhea in intensive care unit patients receiving antibiotic monotherapy . World Journal of Clinical Cases . 8 . 10 . 1908–1915 . May 2020 . 32518780 . 10.12998/wjcc.v8.i10.1908 . free . 7262719 .
  28. Connelly S, Subramanian P, Hasan NA, Colwell RR, Kaleko M . Distinct consequences of amoxicillin and ertapenem exposure in the porcine gut microbiome . Anaerobe . 53 . 82–93 . October 2018 . 29689301 . 10.1016/j.anaerobe.2018.04.012 . 2024-04-08 . live . https://web.archive.org/web/20220803113104/https://linkinghub.elsevier.com/retrieve/pii/S1075996418300696 . 2022-08-03 .
  29. Web site: Amoxicillin: Drug information. Contraindications. . 2024-04-03 . Uptodate..
  30. Web site: Amoxicillin: Drug information. Drug Interactions. . 2024-04-03 . Uptodate..
  31. Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E . Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions . Gastroenterology . 155 . 5 . 1372–1382.e17 . November 2018 . 29990487 . 6905086 . 10.1053/j.gastro.2018.07.007 .
  32. Web site: Clarithromycin: Drug information. Pharmacologic Category. . 2024-04-01 . Uptodate..
  33. Web site: Clarithromycin: Drug information. Use: Labeled Indications . 2024-04-01 . Uptodate..
  34. Web site: Clarithromycin. Uses and Administration. . 2024-04-01 . Martindale. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  35. Chey WD, Leontiadis GI, Howden CW, Moss SF . ACG Clinical Guideline: Treatment of Helicobacter pylori Infection . The American Journal of Gastroenterology . 112 . 2 . 212–239 . February 2017 . 28071659 . 10.1038/ajg.2016.563 .
  36. Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK . 6 . The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults . Gastroenterology . 151 . 1 . 51–69.e14 . July 2016 . 27102658 . 10.1053/j.gastro.2016.04.006 . 2024-04-08 . live . https://web.archive.org/web/20240410173631/https://linkinghub.elsevier.com/retrieve/pii/S0016508516301081 . 2024-04-10 .
  37. Web site: Clarithromycin: Drug information. Dosing: Adult. . 2024-04-01 . Uptodate..
  38. Web site: Clarithromycin: Drug information. Mechanism of Action. . 2024-04-01 . Uptodate..
  39. Web site: Clarithromycin: Drug information.Adverse Reactions. . 2024-04-01 . Uptodate..
  40. Web site: Clarithromycin. Adverse Effects and Precautions. . 2024-04-01 . Martindale. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  41. Web site: Clarithromycin: Drug information. Contraindications. . April 4, 2024 . UpToDate..
  42. Web site: Clarithromycin: Drug information. Drug Interactions. . 2024-04-01 . Uptodate..
  43. Web site: Statins + Macrolides. Importance and Management. . 2024-04-01 . Stockley's Drug Interactions. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  44. Web site: Metronidazole (systemic): Drug information. Dosing: Adult . 2024-04-01 . Uptodate..
  45. Web site: Metronidazole. Antimicrobial Action. . 2024-04-01 . Martindale. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  46. Web site: Metronidazole (systemic): Drug information. Mechanism of Action. . 2024-04-01 . Uptodate..
  47. Web site: Metronidazole (systemic): Drug information. Adverse Reactions. . 2024-04-01 . Uptodate..
  48. Sørensen CG, Karlsson WK, Amin FM, Lindelof M . Metronidazole-induced encephalopathy: a systematic review . Journal of Neurology . 267 . 1 . 1–13 . January 2020 . 30536109 . 10.1007/s00415-018-9147-6 .
  49. Diodato D, Olivieri G, Pro S, Maiorani D, Martinelli D, Deodato F, Taurisano R, Di Capua M, Dionisi-Vici C . 6 . Axonal peripheral neuropathy in propionic acidemia: A severe side effect of long-term metronidazole therapy . Neurology . 91 . 12 . 565–567 . September 2018 . 30120134 . 10.1212/WNL.0000000000006209 .
  50. Kuriyama A, Jackson JL, Doi A, Kamiya T . Metronidazole-induced central nervous system toxicity: a systematic review . Clinical Neuropharmacology . 34 . 6 . 241–247 . November 2011 . 21996645 . 10.1097/WNF.0b013e3182334b35 .
  51. Web site: Metronidazole (systemic): Drug Information. Adverse Reactions (Significant): Considerations. . 2024-04-01 . Uptodate..
  52. Alonzo MM, Lewis TV, Miller JL . Disulfiram-like Reaction With Metronidazole: An Unsuspected Culprit . The Journal of Pediatric Pharmacology and Therapeutics . 24 . 5 . 445–449 . 2019-09-01 . 31598109 . 6782120 . 10.5863/1551-6776-24.5.445 . 2024-04-08 . live . https://web.archive.org/web/20240408155359/https://meridian.allenpress.com/jppt/article/24/5/445/433392/Disulfiramlike-Reaction-With-Metronidazole-An . 2024-04-08 .
  53. Cina SJ, Russell RA, Conradi SE . Sudden death due to metronidazole/ethanol interaction . The American Journal of Forensic Medicine and Pathology . 17 . 4 . 343–346 . December 1996 . 8947362 . 10.1097/00000433-199612000-00013 .
  54. Web site: Metronidazole (systemic): Drug information. Drug interactions. . UpToDate..
  55. Web site: Bismuth subsalicylate: Drug information. Off-label: Adult . 2024-04-01 . Uptodate..
  56. Web site: Bismuth subsalicylate: Drug information. Mechanism of Action . 2024-04-01 . Uptodate..
  57. Web site: Bismuth subsalicylate: Drug information. Dosage Forms: US. . 2024-04-03 . Uptodate..
  58. Web site: Bismuth subsalicylate: Drug information. Adverse Reactions. . 2024-04-01 . Uptodate..
  59. Web site: Bismuth subsalicylate: Drug information. Contraindications. . 2024-04-01 . Uptodate..
  60. Web site: Bismuth compounds + Food. Clinical evidence, mechanism, importance and management. . 2024-04-01 . Stockley's Drug Interactions. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  61. Web site: Omeprazole: Drug information. Mechanism of Action . 2024-04-01 . Uptodate..
  62. Web site: Omeprazole. Directions for administration. . April 4, 2024 . British national formulary..
  63. Hershcovici T, Fass R . An algorithm for diagnosis and treatment of refractory GERD . Best Practice & Research. Clinical Gastroenterology . 24 . 6 . 923–936 . December 2010 . 21126704 . 10.1016/j.bpg.2010.10.004 .
  64. Web site: Omeprazole. Uses and Administration. . 2024-04-01 . Martindale. . 2023-03-13 . https://web.archive.org/web/20230313034418/https://login.eproxy.lib.hku.hk/login?qurl=https://www.medicinescomplete.com%2f . live .
  65. Leonard J, Marshall JK, Moayyedi P . Systematic review of the risk of enteric infection in patients taking acid suppression . The American Journal of Gastroenterology . 102 . 9 . 2047–56; quiz 2057 . September 2007 . 17509031 . 10.1111/j.1572-0241.2007.01275.x .
  66. Aydın Yoldemir Ş, Zeren Ozturk G, Akarsu M, Ozcan M . Is there a correlation between hypomagnesemia linked to long-term proton pump inhibitor use and the active agent? . Wiener Klinische Wochenschrift . 134 . 3–4 . 104–109 . February 2022 . 33751184 . 10.1007/s00508-021-01834-x .
  67. Lam JR, Schneider JL, Zhao W, Corley DA . Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency . JAMA . 310 . 22 . 2435–2442 . December 2013 . 24327038 . 10.1001/jama.2013.280490 .
  68. Nassar Y, Richter S . Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis . Journal of Bone Metabolism . 25 . 3 . 141–151 . August 2018 . 30237993 . 6135649 . 10.11005/jbm.2018.25.3.141 .
  69. Ricketson J, Kimel G, Spence J, Weir R . Acute allergic interstitial nephritis after use of pantoprazole . CMAJ . 180 . 5 . 535–538 . March 2009 . 19255077 . 2645468 . 10.1503/cmaj.080456 .
  70. Web site: Omeprazole: Drug information. Warnings/Precautions. . 2024-04-01 . Uptodate..
  71. Web site: Omeprazole: Drug information. Contraindications. . 2024-04-03 . Uptodate..
  72. Web site: Omeprazole: Drug information. Drug Interactions. . 2024-04-01 . Uptodate..
  73. Schaier M, Scholl C, Scharpf D, Hug F, Bönisch-Schmidt S, Dikow R, Schmitt WH, Schwenger V, Zeier M, Sommerer C . 6 . Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil . Rheumatology . 49 . 11 . 2061–2067 . November 2010 . 20671023 . 10.1093/rheumatology/keq238 . 2024-04-08 . live . https://web.archive.org/web/20240415061150/https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/keq238 . 2024-04-15 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Anti-ulcer agents".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.